LU83657A1 - Halogenures d'ammonium spiro-quaternaire,leur procede de preparation et leur utilisation dans un procede de production de n-(2-pyrimidinyl)piperazinyl-alkylazospiro-alcanediones - Google Patents

Halogenures d'ammonium spiro-quaternaire,leur procede de preparation et leur utilisation dans un procede de production de n-(2-pyrimidinyl)piperazinyl-alkylazospiro-alcanediones Download PDF

Info

Publication number
LU83657A1
LU83657A1 LU83657A LU83657A LU83657A1 LU 83657 A1 LU83657 A1 LU 83657A1 LU 83657 A LU83657 A LU 83657A LU 83657 A LU83657 A LU 83657A LU 83657 A1 LU83657 A1 LU 83657A1
Authority
LU
Luxembourg
Prior art keywords
pyrimidinyl
formula
spiro
equal
aza
Prior art date
Application number
LU83657A
Other languages
English (en)
French (fr)
Inventor
Jack C Simms
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22729338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU83657(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83657A1 publication Critical patent/LU83657A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU83657A 1980-10-16 1981-09-28 Halogenures d'ammonium spiro-quaternaire,leur procede de preparation et leur utilisation dans un procede de production de n-(2-pyrimidinyl)piperazinyl-alkylazospiro-alcanediones LU83657A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/197,416 US4351939A (en) 1980-10-16 1980-10-16 Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
US19741680 1980-10-16

Publications (1)

Publication Number Publication Date
LU83657A1 true LU83657A1 (fr) 1982-04-14

Family

ID=22729338

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83657A LU83657A1 (fr) 1980-10-16 1981-09-28 Halogenures d'ammonium spiro-quaternaire,leur procede de preparation et leur utilisation dans un procede de production de n-(2-pyrimidinyl)piperazinyl-alkylazospiro-alcanediones

Country Status (33)

Country Link
US (1) US4351939A (de)
JP (2) JPS5724384A (de)
KR (2) KR870000321B1 (de)
AT (1) AT382153B (de)
AU (1) AU524822B2 (de)
BE (1) BE890509A (de)
CA (1) CA1175832A (de)
CH (1) CH647778A5 (de)
CY (1) CY1325A (de)
DE (1) DE3141256C2 (de)
DK (1) DK148481C (de)
ES (2) ES501994A0 (de)
FI (1) FI75159C (de)
FR (1) FR2492383A1 (de)
GB (1) GB2085436B (de)
GR (1) GR74687B (de)
HK (1) HK35386A (de)
HU (2) HU185967B (de)
IE (1) IE51646B1 (de)
IL (1) IL64047A (de)
IT (1) IT1143244B (de)
KE (1) KE3596A (de)
LU (1) LU83657A1 (de)
MY (1) MY8600475A (de)
NL (2) NL179055C (de)
NZ (1) NZ196974A (de)
OA (1) OA06920A (de)
PT (1) PT73824B (de)
SE (2) SE439167B (de)
SG (1) SG97885G (de)
SU (1) SU1342420A3 (de)
YU (2) YU42565B (de)
ZA (1) ZA812759B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
JPS5945380U (ja) * 1982-09-20 1984-03-26 いすゞ自動車株式会社 車両用帯状体の固定装置
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
CA2146593A1 (en) * 1994-05-05 1995-11-06 Jack Melton Large-scale process for azapirone synthesis
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
TW200302728A (en) * 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
JP5264488B2 (ja) * 2005-08-30 2013-08-14 ハネウェル・インターナショナル・インコーポレーテッド スピロ四級アンモニウム系の合成方法
CN101089000B (zh) 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
CN101362751B (zh) * 2007-08-10 2011-05-11 成都科瑞德医药投资有限责任公司 枸橼酸坦度螺酮及其制备方法、制剂和质量控制方法
ES2594709T3 (es) * 2010-04-26 2016-12-22 Sumitomo Dainippon Pharma Co., Ltd. Un proceso de preparación de una sal de amonio cuaternario
ES2527545T3 (es) * 2010-04-26 2015-01-26 Sumitomo Dainippon Pharma Co., Ltd. Un procedimiento de preparación de una sal de amonio cuaternario utilizando fosfato
IT201900000657A1 (it) 2019-01-16 2020-07-16 Procos Spa Processo per la sintesi di gepirone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948730A (en) * 1959-04-08 1964-02-05 Wellcome Found Substituted cyclopropanes and related compounds
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation

Also Published As

Publication number Publication date
US4351939A (en) 1982-09-28
NL8501430A (nl) 1985-09-02
FR2492383B1 (de) 1985-01-25
CY1325A (en) 1986-06-27
NZ196974A (en) 1983-05-31
IL64047A0 (en) 1982-01-31
SE447257B (sv) 1986-11-03
PT73824B (en) 1983-10-31
BE890509A (fr) 1982-03-25
YU43316B (en) 1989-06-30
OA06920A (fr) 1983-05-31
YU42565B (en) 1988-10-31
CH647778A5 (de) 1985-02-15
NL8104660A (nl) 1982-05-17
YU110381A (en) 1983-12-31
DK433781A (da) 1982-04-17
IE51646B1 (en) 1987-01-21
IE812420L (en) 1982-04-16
HK35386A (en) 1986-05-30
KE3596A (en) 1986-02-07
FI75159C (fi) 1988-05-09
AU524822B2 (en) 1982-10-07
ES511079A0 (es) 1983-03-16
DK148481C (da) 1985-12-16
YU136083A (en) 1986-02-28
FI75159B (fi) 1988-01-29
ZA812759B (en) 1982-05-26
ES8206516A1 (es) 1982-08-16
FI813178L (fi) 1982-04-17
DK148481B (da) 1985-07-15
KR830007659A (ko) 1983-11-04
GB2085436B (en) 1984-01-18
JPS634828B2 (de) 1988-02-01
MY8600475A (en) 1986-12-31
CA1175832A (en) 1984-10-09
ATA444681A (de) 1986-06-15
GB2085436A (en) 1982-04-28
HU187999B (en) 1986-03-28
IT8149476A0 (it) 1981-10-13
NL179055B (nl) 1986-02-03
DE3141256A1 (de) 1982-08-19
AU7029281A (en) 1982-04-22
SE8600174D0 (sv) 1986-01-15
AT382153B (de) 1987-01-26
GR74687B (de) 1984-07-03
IT1143244B (it) 1986-10-22
KR890000465B1 (ko) 1989-03-18
JPS61178983A (ja) 1986-08-11
SG97885G (en) 1986-07-25
JPS6153353B2 (de) 1986-11-17
SE8600174L (sv) 1986-01-15
JPS5724384A (en) 1982-02-08
NL179055C (nl) 1986-07-01
IL64047A (en) 1984-12-31
FR2492383A1 (fr) 1982-04-23
SE8106060L (sv) 1982-04-17
DE3141256C2 (de) 1986-06-05
KR870000321B1 (en) 1987-02-27
HU185967B (en) 1985-04-28
PT73824A (en) 1981-11-01
SE439167B (sv) 1985-06-03
SU1342420A3 (ru) 1987-09-30
ES501994A0 (es) 1982-08-16
ES8304967A1 (es) 1983-03-16

Similar Documents

Publication Publication Date Title
LU83657A1 (fr) Halogenures d'ammonium spiro-quaternaire,leur procede de preparation et leur utilisation dans un procede de production de n-(2-pyrimidinyl)piperazinyl-alkylazospiro-alcanediones
RU2017736C1 (ru) 5,6-дигидро-2-(замещенный фенил)-1,2,4-триазин-3,5-(2н,4н)-дионы, обладающие противококсидиальной и коксидиостатической активностью
DE69411317T2 (de) Indoloylguanidinderivate als Inhibitoren des Natrium-Protonen Austauschs
EP0434561B1 (de) Derivate von 1-Naphthylpiperazin, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
LU84561A1 (fr) 2-(4-((4,4,-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyrimidines
Firke et al. Synthetic and pharmacological evaluation of some pyridine containing thiazolidinones
CN105452251A (zh) 作为β-分泌酶(BACE)抑制剂的4-氨基-6-苯基-5,6-二氢咪唑并[1,5-A]吡嗪-3(2H)-酮衍生物
LU84562A1 (fr) 2-(4-((4,4-dialcoyl-2,6-piperidinedione-1-yl)butyl)-1-piperazinyl)pyridines
RU2174978C2 (ru) Способ получения производных пиримидина, промежуточные продукты и способ их получения
EP0309324A1 (de) Verfahren zur Herstellung von N-alkylierten Aminosäuren und deren Estern, Verwendung zur Synthese von Carboxyalkyldipeptiden
EP0406112A1 (de) 1-Benzhydrylazetidine, deren Herstellung und Verwendung als Zwischenprodukte zur Herstellung von Verbindungen mit antimikrobieller Wirkung
US2543345A (en) Method of preparing glutamic acid amides
JPH0357895B2 (de)
KR20010043033A (ko) 신규한옥타히드로-6,10-디옥소-6Ｈ-피리다지노[1,2-ａ][1,2]디아제핀-1-카르복실산 유도체, 그의 제조 방법 및 치료적 활성화합물의 제조용 용도
US4417049A (en) Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
FR2616433A1 (fr) Nouveaux derives piperazinyl alkyl piperazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPS5833877B2 (ja) ユウキカゴウブツニカンスルカイリヨウ
FI63758C (fi) Foerfarande foer framstaellning av 1-(2-tetrahydrofuryl)-5-fluoruracil
HU194164B (en) Process for production of 1,2-dihydroxi-3-//2-indolil-1,1-dialkyl-ethil/-amin/-prophanes
RU2225866C1 (ru) Калиевая соль 2-[5(6)-нитро-1-(тиетанил-3)-бензимидазолил-2-тио]уксусной кислоты, проявляющая кардиотоническую активность
EP0199485B1 (de) Zwischenprodukte und Verfahren
JP2002155058A (ja) １位置換ヒダントイン類の製造方法
JPS62292771A (ja) ベンゾグアナミン誘導体の製法
FR2555582A1 (fr) Procede de preparation de 4-(2-phenoxyethyl)-1,2,4-triazolone
JPH072802A (ja) 光学活性トリアゾール誘導体の製造法